TipRanks on MSN

Marzocchi Pompe S.p.A. Announces Share Buyback Program

Marzocchi Pompe S.p.A. ( ($IT:MARP) ) just unveiled an announcement. Marzocchi Pompe S.p.A. announced the purchase of 2,250 ...
Nasdaq

Marzocchi Pompe S.p.A. Completes Share Buy-Back Program

Marzocchi Pompe S.p.A. (IT:MARP) has released an update. Marzocchi Pompe S.p.A. has completed its share buy-back program, acquiring a total of 3,250 shares between October 7 and 25, 2024, at an ...
Zonebourse

Marzocchi Pompe lance un programme de rachat et de cession d'actions propres

Marzocchi Pompe S.p.A. annonce ses résultats pour l'exercice clos le 31 décembre 2024 31/03 CI Revenus et bénéfices en baisse pour Marzocchi Pumps au cours de l'exercice 2024 28/03 AN Marzocchi Pompe ...
Business Wire

Amicus Therapeutics Launches Amicus Ignite, a Proactive Community Funding Programme for Initiatives That Support People Living With Pompe Disease

Funding of up to €20,000 (or local currency equivalent), per application, for a limited number of projects is available to organisations and projects located outside of the United States. Projects ...
Nasdaq

AVROBIO Presents New Preclinical Data on Lentiviral Gene Therapy Program for Pompe Disease at ASGCT 2020

AVROBIO’s optimized lentiviral vectors demonstrate significant glycogen reduction in the muscle and central nervous system of Pompe disease mouse model Investigational New Drug (IND)-enabling proof-of ...
Business Wire

AVROBIO Presents New Preclinical Data on Lentiviral Gene Therapy Program for Pompe Disease at ASGCT 2020

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced new ...